A novel model for Ki67 assessment in breast cancer.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

30 Citeringar (SciVal)
158 Nedladdningar (Pure)

Sammanfattning

Ki67 is currently the proliferation biomarker of choice, with both prognostic and predictive value in breast cancer. A lack of consensus regarding Ki67 use in pre-analytical, analytical and post-analytical practice may hinder its formal acceptance in the clinical setting.
Originalspråkengelska
Artikelnummer118
TidskriftDiagnostic Pathology
Volym9
Utgåva1
DOI
StatusPublished - 2014

Bibliografisk information

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Pathology, (Lund) (013030000), Oncology, MV (013035000)

Ämnesklassifikation (UKÄ)

  • Cancer och onkologi

Fingeravtryck

Utforska forskningsämnen för ”A novel model for Ki67 assessment in breast cancer.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här